Update of the 2010 Australian Guidelines for the Prevention and Control of Infection in Healthcare (2010 Guidelines)
Developing or revising guidelines aimed at the prevention and control of infection in healthcare is an example of NHMRC’s strategic priority of ‘effective translation of evidence to improve clinical outcomes and public and environmental health’. The Corporate Plan 2015-2016 identifies key activities that fall under this priority and include providing national leadership in promoting translation of knowledge created through research into clinical practice, health policy and health services and systems. Working with the Australian Commission on Safety and Quality in HealthCare (ACSQHC) to update the Australian Guidelines for the Prevention and Control of Infection in Healthcare is a specified target.
The update of the 2010 Guidelines is envisaged to be completed in late 2018. Within this timeframe as there are a number of major processes involved in updating the Guidelines, including:
- Identification of current international and national guidelines and literature on Infection Prevention and Control in HealthCare and how they relate to the current 2010 Guidelines;
- Systematic and Literature Reviews to address identified scientific questions;
- Methodological Review of the Systematic and Literature Reviews;
- Updating of recommendations and text within the Guideline to reflect the latest evidence and practices (where appropriate); and
- Expert Review of the draft updated 2010 Guidelines.
The NHMRC in consultation with ACSQHC established an Infection Control Guidelines Advisory Committee (ICGAC) to provide guidance and advice on this project.
Appointment Process for the Committee
The Infection Control Guidelines Advisory Committee is an advisory committee established by a CEO delegate, under section 39 of the National Health and Medical Research Council Act 1992. The committee was selected to ensure appropriate expertise in the key areas of infectious diseases, antimicrobial resistance and/or microbiology, healthcare associated infection, paediatrics, evidence-based methodologies (e.g. epidemiology, systematic review methodology), inflection control in a dental setting, Aboriginal and Torres Strait Islander health and consumer representation.
Terms of Reference
The Infection Control Guidelines Advisory Committee will oversee and provide expertise in updating the Australian Guidelines for the Prevention and Control of Infection in Healthcare (2010 Guidelines) to ensure it reflects the best available evidence and is current and relevant for the Australian context. As per the 2010 Guidelines, the updated guidelines will aim to promote and facilitate the overall goal of infection prevention and control: ‘The creation of safe healthcare environments through the implementation of practices that minimise the risk of transmission of infectious agents’.
The Infection Control Guidelines Advisory Committee will:
- Determine the scope of the guideline update based on consideration of:
- the currency, accuracy and relevance of the existing 2010 Guidelines;
- feedback provided by the broader community and healthcare sector on the 2010 Guidelines, including new areas for potential inclusion;
- the results of a horizon scan funded by the Australian Commission on Safety and Quality in Health Care (the Commission), that identifies and assesses the quality of guidelines published since the 2010 Guidelines;
- committee member’s knowledge/expertise of current evidence or practice in infection prevention and control in Australia; and
- any other information deemed relevant by the Office of NHMRC or the Commission.
- Advise on the evidence evaluation required to update the 2010 Guidelines by:
- identifying and prioritising topics requiring the identification of new evidence published since the search period for the 2010 Guidelines; and
- advising on the scope and clinical questions for the evaluation/s, and methods to identify and evaluate relevant evidence.
- Oversee the update of the 2010 Guidelines by considering (1) and (2) above. This may include, but is not limited to providing advice on:
- developing recommendations using NHMRC’s preferred method;
- key stakeholders to be included in consultation activities; and
- comments received during consultation and expert review on the draft revised Guidelines.
The Infection Control Guidelines Advisory Committee will report to NHMRC’s Council.
Appointments to the Infection Control Guidelines Advisory Committee commenced on 25 January 2016 and will be effective until 31 December 2018.
Contact the Infection Control Guidelines Advisory Committee
Infection Control Guidelines Team
National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601
Please note: Members of the Infection Control Guidelines Advisory Committee are unable to respond to individual enquiries.
Member information and Disclosure of Interests
NHMRC asked each Infection Control Guideline Advisory Committee member to document their interests, as part of the process of the establishment of any NHMRC committee. Members were asked to consider perceived interests as well as real interests.
Members were specifically asked to identify, to the best of their ability, interests relating to infection control guideline work including:
- relevant financial activities;
- relevant professional or organisational experience; and
- other relationships or activities.
Throughout the project members are required to inform NHMRC of any changes to their interests, and management strategies are put in place as needed.
Infection Control Guidelines Advisory Committee Members
Professor Brett Mitchell (Chair)
Professor of Nursing, Faculty of Nursing and Health and Director Lifestyle Research Centre – Avondale College.
Infection Prevention and Control
Professor Allen Cheng
Professor of Infectious Diseases Epidemiology and the Director of Infection Prevention and Healthcare Epidemiology Unit at Alfred Health.
Infectious Disease Physician and Epidemiology
Professor Peter Collignon AM
Executive Director, ACT Pathology; Infectious Diseases Physician and Microbiologist - Canberra Hospital and Professor, Medical School at the Australian National University.
Infectious Disease Physician, Clinical Microbiology and Antimicrobial Resistance
Ms Sylvia Gandossi
Infection Prevention and Control Consultant, Western Diagnostics Pathology; Member, Australasian College for Infection Prevention and Control.
Infection Prevention and Control
Dr Thomas Gottlieb
Senior Staff Specialist Microbiology and Infectious Diseases – Concord Hospital; Clinical Associate Professor, Department of Microbiology and Infectious Diseases – University of Sydney.
Infectious diseases, Microbiology and Antimicrobial Resistance (AMR
Dr Jan Gralton
Senior Project Officer – Australian Commission on Safety and Quality in HealthCare.
Ms Linda Henderson
Infection Control Consultant; Infection Control Nurse Advisor – South Australian Health; Member of the Commission’s National Hand Hygiene Advisory Committee.
Healthcare Associated Infections
Dr Sharon Liberali
Senior Clinical Lecturer – School of Dentistry at the University of Adelaide; Clinical Examiner – Australian Dental Council; Clinical Supervisor; Chair, Infection Control Committee – Australian Dental Association.
Dr Deborough Macbeth
Assistant Director of Nursing – Gold Coast Hospital and Health Service
Healthcare Associated Infections and Nursing
Ms Rebecca McCann
Program Manager, Healthcare Associated Infection Unit, Communicable Disease Control Directorate – Department of Health (Western Australia)
Professor Peter Morris
Deputy Head, Child Health Division, Menzies School of Health Research; Editor, Acute Respiratory Infections Group of The Cochrane Collaboration.
Aboriginal and Torres Strait Islander Health, Paediatrics and Evidence Based Practice
Ms Mary Potter
Active in both state and national health issues from a consumer/community stand point; A member on numerous healthy committees in New South Wales; previous member of the Board – Australasian College of Infection Prevention and Control.
Dr Philip Russo
Research Fellow, Deakin/Alfred Centre for Quality and Patient Safety Research.
Infection Prevention and Epidemiology